两面针又要扩产了，还是针对酒店牙膏和拖鞋项目。 作为原本的国民牙膏品牌，两面针在被"挤出"主流家用牙膏市场后，逐渐将旅游牙膏作为业务重点。只是，尽管保持着行业领先的市占率，但其盈利能力 出现明显的下滑。 要知道，在第三季度，两面针一支旅游牙膏只卖8分钱。并且，这样的售价几乎维持了近十年时间。 深耕酒店业务，似乎并没有让两面针发扬壮大。押宝酒店，但又困于酒店，这不是两面针一家企业面临的难题。几乎所有传统耗品企业品牌都有类似的遭 遇。 究竟是酒店赛道天然存在利润不足，还是外界多重因素压榨了供应链企业的利润？这非常值得我们关注。 酒店牙膏，是解药也是毒药？ 在扬州杭集镇，两面针正在筹划建设中草药功能性口腔护理产品生产基地扩建项目。该公司计划投资6885.22 万元，建设一个牙膏生产车间和酒店用拖鞋 生产车间。 图源：两面针公告 前者将整合现有牙膏生产线，满足公司酒店牙膏生产需要的同时，满足客户 OEM 等定制类产品要求。后者则将有效降低对外采购依赖，完善产品配套能 力，巩固并提升市场份额。 两面针的确需要扩大酒店牙膏产能，因为原本设计的产能几乎已经满产了。 两面针最近一次披露产能利用率是在2024年财报中。 数据显 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600249 证券简称：两面针 公告编号：临2025-040 柳州两面针股份有限公司关于召开2025年第二次临时股东 大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东大会召开日期：2025年12月12日 (一)股东大会类型和届次 2025年第二次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络 投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025年12月12日 10点 00分 召开地点：广西柳州市东环大道282号本公司五楼会议室 无 二、会议审议事项 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025年12月12日 至2025年12月12日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东大会召开当日的交易时间 段，即9:15-9:25,9:30-11:30， ...

Core Viewpoint - The company is expanding its production capacity by investing in a new manufacturing base for functional oral care products in Jiangsu Province, aiming to enhance operational efficiency and product quality while integrating smart manufacturing technologies [2][4]. Group 1: Project Details - The total investment for the expansion project is estimated at 68.85 million yuan, with construction costs accounting for 45.39 million yuan and equipment and software purchases at 23.46 million yuan [3]. - The project will involve the construction of a six-story factory building with a total area of 22,749 square meters, including a toothpaste production workshop of 18,199 square meters and a hotel slipper production workshop of 4,550 square meters [2][3]. - The construction period is expected to last 14 months, with equipment purchases and capacity integration implemented in phases based on market conditions [3]. Group 2: Business Overview - The company operates in two main sectors: daily chemicals and pharmaceuticals, focusing on the "big consumption, big health" industry [3]. - The daily chemicals segment includes the development, production, and sales of oral care products, personal care items, and hotel supplies, with key brands such as Two-Mouth Needle and Mu Lan Ze [3]. - The pharmaceutical segment produces and sells various medications, including capsules and raw materials, managed by Yikang Pharmaceutical [3]. Group 3: Financial Performance - The Jiangsu company has shown stable operational performance, with projected revenues of 761 million yuan for 2024 and 437 million yuan for the first half of 2025, alongside net profits of 11.95 million yuan and 6.44 million yuan, respectively [3]. - The company has identified a growing need for capacity support and equipment efficiency improvements due to increasing market orders, which has impacted order fulfillment and limited sustainable growth [3][4]. Group 4: Strategic Implications - The project aims to overcome existing capacity bottlenecks by introducing advanced equipment and optimizing production processes, thereby enhancing automation and production efficiency [4]. - The establishment of a hotel slipper production line will reduce reliance on external suppliers and improve product offerings, thereby strengthening market share [4]. - The new facility is expected to provide better conditions for research and innovation, facilitating the iterative upgrade of herbal functional products to meet diverse market demands [4].